Comparative study of the binding mode between cytochrome P450 17A1 and prostate cancer drugs in the absence of haem iron

References

• Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., … de Bono, J. S. (2008). Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. Journal of Clinical Oncology, 26(28), 4563–4571.
   PubMed Web of Science ®Google Scholar
• Aragon-Ching, J. B., Williams, K. M., & Gulley, J. L. (2007). Impact of androgen-deprivation therapy on the immune system: implication for combination therapy of prostate cancer. Frontiers in Bioscience, 12(12), 4957–4971.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Grigera, J. R., & Straatsma, T. P. (1987). The missing term in effective pair potentials. The Journal of Physical Chemistry, 91(24), 6269–6271.
   Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. Journal of Chemical Physics, 126(1), 014101.
   PubMed Web of Science ®Google Scholar
• Cai, C., Chen, S., Ng, P., Bubley, G. J., Nelson, P. S., Mostaghel, E. A., … Balk, S. P. (2011). Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Research, 71(20), 6503–6513.
   PubMed Web of Science ®Google Scholar
• Cieplak, P., Cornell, W. D., Bayly, C. I., & Kollman, P. A. (1995). Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins. Journal of Computational Chemistry, 16(11), 1357–1377.
   Web of Science ®Google Scholar
• Cojocaru, J., Winn, P. J., & Wade, R. C. (2007). The ins and outs of cytochrome P450s. Biochimica et Biophysica Acta, 1770(3), 390–401.
   PubMed Web of Science ®Google Scholar
• Collier, A., Ghosh, S., McGlynn, G., & Hollins, G. (2012). Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease. A Review. American Journal of Clinical Oncology, 35(5), 504–509.
   PubMed Web of Science ®Google Scholar
• Cui, Y. L., Zhang, J. L., Zheng, Q. C., Niu, R. J., Xu, Y., Zhang, H. X., & Sun, C. C. (2013). Structural and dynamic basis of human cytochrome P450 7B1: A survey of substrate selectivity and major active site access channels. Chemistry – A European Journal, 19(2), 549–557.
   PubMed Web of Science ®Google Scholar
• Cui, Y. L., Zheng, Q. C., Zhang, J. L., Xue, Q., Wang, Y., & Zhang, H. X. (2013). Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1. Journal of Chemical Information and Modeling, 53(12), 3308–3317.
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: an N⋅ log (N) method for Ewald sums in large systems. Journal of Chemical Physics, 98(12), 10089–10092.
   Web of Science ®Google Scholar
• Devore, N. M., & Scott, E. E. (2012). Structures of cytochrome P450 17 A1 with prostate cancer drugs abiraterone and TOK-001. Nature, 482(7383), 116–120.
   PubMed Web of Science ®Google Scholar
• Frisch, M., Trucks, G., Schlegel, H., Scuseria, G., Robb, M., Cheeseman, J., … Petersson, G. (2009). Gaussian 09, revision A.02. Wallingford, CT: Gaussian.
   Google Scholar
• Gerogiokas, G., Southey, M. W., Mazanetz, M. P., Hefeitz, A., Bodkin, M., Law, R., & Michel, J. (2015). Evaluation of water displacement energetics in protein binding sites with grid cell theory. Physical Chemistry Chemical Physics, 17(13), 8416–8426.
   PubMed Web of Science ®Google Scholar
• Grönberg, H. (2003). Prostate cancer epidemiology. The Lancet, 361(9360), 859–864.
   PubMed Web of Science ®Google Scholar
• Henzler-Wildman, K. A., Thai, V., Lei, M., Ott, M., Wolf-Watz, M., Fenn, T., … Kern, D. (2007a). Intrinsic motions along an enzymatic reaction trajectory. Nature, 450(7171), 838–844.
   PubMed Web of Science ®Google Scholar
• Henzler-Wildman, K. A., Lei, M., Thai, V., Kerns, S. J., Karplus, M., & Kern, D. (2007b). A hierarchy of timescales in protein dynamics is linked to enzyme catalysis. Nature, 450(7171), 913–916.
   PubMed Web of Science ®Google Scholar
• Hess, B. (2008). P-LINCS: a parallel linear constraint solver for molecular simulation. Journal of Chemical Theory and Computation, 4(1), 116–122.
   PubMed Web of Science ®Google Scholar
• Hess, B., Kutzner, C., Van Der Spoel, D., & Lindahl, E. (2008). GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4(3), 435–447.
   PubMed Web of Science ®Google Scholar
• Houston, K. A., King, J., Li, J., & Jemal, A. (2018). Trends in prostate cancer incidence rates and prevalence of prostate specific antigen screening by socioeconomic status and regions in the United States, 2004 to 2013. Journal of Urology, 199(3), 676–682.
   PubMed Web of Science ®Google Scholar
• Kantoff, P. W., Schuetz, T. J., Blumenstein, B. A., Glode, L. M., Bilhartz, D. L., Wyand, M., … Godfrey, W. R. (2010). Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology, 28(7), 1099–1105.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Bouzida, D., Swendsen, R. H., Kollman, P. A., & Rosenberg, J. M. (1992). The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. Journal of Computational Chemistry, 13(8), 1011–1021.
   Web of Science ®Google Scholar
• Larsen, M., Hansen, C. H., Rasmussen, T. B., Islin, J., Styrishave, B., Olsen, L., & Jørgensen, F. S. (2017). Structure-based optimisation of non-steroidal cytochrome P450 17A1 inhibitors. Chemical Communications, 53(21), 3118–3121.
   PubMed Web of Science ®Google Scholar
• Steele, C. B., Li, J., Huang, B., & Weir, H. K. (2017). Prostate cancer survival in the United States by Race and Stage (2001-2009): findings from the CONCORD-2 study. Cancer, 123, 5160–5177.
   PubMed Web of Science ®Google Scholar
• Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the AMBER ff99SB protein force field. Proteins: Structure, Function, and Bioinformatics, 78, NA–958.
   Web of Science ®Google Scholar
• Mostaghel, E. A., Marck, B. T., Plymate, S. R., Vessella, R. L., Balk, S., Matsumoto, A. M., … Montgomery, R. B. (2011). Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clinical Cancer Research, 17(18), 5913–5925.
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: a new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190.
   Web of Science ®Google Scholar
• Scott, W. R. P., Hünenberger, P. H., Tironi, I. G., Mark, A. E., Billeter, S. R., Fennen, J., … van Gunsteren, W. F. (1999). The GROMOS biomolecular simulation program package. The Journal of Physical Chemistry A, 103(19), 3596–3607.
   Web of Science ®Google Scholar
• Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE-antechamber python parse interface. BMC Research Notes, 5(1), 367.
   PubMedGoogle Scholar
• Stocker, U., & van Gunsteren, W. F. (2000). Molecular dynamics simulation of hen egg white lysozyme: a test of the GROMOS96 force field against nuclear magnetic resonance data. Proteins: Structure, Function, and Genetics, 40(1), 145–153.
   PubMed Web of Science ®Google Scholar
• Sun, H., Li, Y., Tian, S., Wang, J., & Hou, T. (2014). P-loop conformation governed crizotinib resistance in G2032R-mutated ROS1 tyrosine kinase: clues from free energy landscape. PLoS Computational Biology, 10(7), e1003729.
   PubMed Web of Science ®Google Scholar
• Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., … Murphy, K. C. (1996). Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. Journal of Clinical Oncology, 14(6), 1756–1764.
   PubMed Web of Science ®Google Scholar
• Torrie, G. M., & Valleau, J. P. (1977). Non-physical sampling distributions in Monte-Carlo free-energy estimation-umbrella sampling. Journal of Computational Physics, 23(2), 187–199.
   Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174.
   PubMed Web of Science ®Google Scholar
• Xiao, F., Yang, M., Xu, Y., & Vongsangnak, W. (2015). Comparisons of prostate cancer inhibitors abiraterone and TOK-001 binding with CYP17A1 through molecular dynamics. Computational Structural Biotechnology Journal, 13, 520–527.
   PubMed Web of Science ®Google Scholar
• Yin, L., & Hu, Q. (2014). CYP17 Inhibitors-abiraterone, C17, 20-lyase inhibitors and multi-targeting agents. Nature Reviews Urology, 11(1), 32–42.
   PubMed Web of Science ®Google Scholar